Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Anixa Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Anixa Biosciences, Inc.’s stock price such as:

• Anixa Biosciences, Inc.’s current stock price and volume
• Why Anixa Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for ANIX from analysts
• ANIX’s stock price momentum as measured by its relative strength

About Anixa Biosciences, Inc. (ANIX)

Before we jump into Anixa Biosciences, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Want to learn more about Anixa Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Anixa Biosciences, Inc..

Anixa Biosciences, Inc.’s Stock Price as of Market Close

As of January 30, 2026, 4:00 PM, CST, Anixa Biosciences, Inc.’s stock price was $3.040.

Anixa Biosciences, Inc. is down 1.94% from its previous closing price of $3.100.

During the last market session, Anixa Biosciences, Inc.’s stock traded between $2.980 and $3.130. Currently, there are approximately 32.94 million shares outstanding for Anixa Biosciences, Inc..

Anixa Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Anixa Biosciences, Inc. Stock Price History

Anixa Biosciences, Inc.’s (ANIX) price is currently down 2.56% so far this month.

During the month of January, Anixa Biosciences, Inc.’s stock price has reached a high of $3.580 and a low of $2.950.

Over the last year, Anixa Biosciences, Inc. has hit prices as high as $5.457 and as low as $2.331. Year to date, Anixa Biosciences, Inc.’s stock is down 2.56%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Anixa Biosciences, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of January 30, 2026,, no analysts have changed their rating of Anixa Biosciences, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Anixa Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Anixa Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Anixa Biosciences, Inc. (ANIX) by visiting AAII Stock Evaluator.

Relative Price Strength of Anixa Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 30, 2026, Anixa Biosciences, Inc. has a weighted four-quarter relative price strength of -5.95%, which translates to a Momentum Score of 31 and is considered to be Weak.

Want to learn more about how Anixa Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Anixa Biosciences, Inc. Stock Price: Bottom Line

As of January 30, 2026, Anixa Biosciences, Inc.’s stock price is $3.040, which is down 1.94% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Anixa Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.